← brief for 2026-08-10 · Slowing decline

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Key takeaways

This study tests a drug called AP306 in adults on dialysis who have too much phosphate in their blood, a common and dangerous problem. It checks safety and whether fixed doses lower phosphate. It is just starting, so there are no results yet.

Who did this work

Run by R1 Therapeutics.
Sites: Apogee Clinical Research, LLC · California Institute of Renal Research · Academic Medical Research Institute · North America Research Institute · Colorado Kidney Care · DaVita Clinical Research

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-08-03
https://clinicaltrials.gov/study/NCT06712654